Savant Capital’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,802
Closed -$247K 1954
2025
Q1
$247K Buy
+13,802
New +$247K ﹤0.01% 1314